Clinical trial
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant…
NCT00467051 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00467051 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors |
| Official title | Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Malignant Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Ovarian Choriocarcinoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor and 6 more |
| Intervention type | Biological, Drug, Other |
| Interventions | Carboplatin, Filgrastim, Ifosfamide, Laboratory Biomarker Analysis, Paclitaxel |
| Enrollment | 20 |
| Start date | Nov 5, 2007 |
| Primary completion | Mar 1, 2012 |
| Completion | Jun 30, 2018 |
| First posted | Apr 27, 2007 |
| Last update posted | Aug 29, 2018 |
| Countries | Australia, Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: